Foods
Cure8 research brief
The Emerging Role of Postbiotics Against Microplastics-Induced Inflammatory Bowel Disease
Research and clinical trials
Basic Science
Researchers
Clinicians
Adult patients
Inflammatory bowel disease
Why This Matters
Microplastics may contribute to IBD pathogenesis, and the review suggests postbiotics could counteract microplastics’ harmful effects on the gut—an emerging environmental and therapeutic concern for people with IBD.
Who Should Pay Attention
Researchers on microplastics and microbiome, clinicians following environmental risk factors for IBD, and patients interested in emerging non-pharmacologic gut-support strategies.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The article is a review (abstract-level content available here) describing mechanisms by which postbiotics might reduce microplastics-induced intestinal injury: anti-inflammatory and immunomodulatory effects, inhibition of pathogenic bacteria, and maintenance of the intestinal barrier.
It focuses on experimental and mechanistic literature rather than clinical trial results. The piece defines postbiotics and discusses their biological roles in preventing or treating IBD triggered or worsened by microplastics, but it does not report new patient-level outcomes or clinical recommendations.
Keep In Mind
This is a review (abstract-level summary). It describes experimental/mechanistic evidence rather than clinical trial results; postbiotics remain an investigational approach for microplastics-related gut injury.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationFoods
AuthorsNader Khani, Shadi Rajabi, Mohammadreza Ziavand +4 more
InstitutionTabriz University of Medical Sciences
Study typeArticle
Indexed viaOpenAlex
Source typeResearch paper
PublishedOct 30, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Lactobacillus johnsonii mediates the protective effects of pristimerin against ulcerative colitis and concomitant liver injury through remodeling hepatic lipid metabolism via LXRα-SCD1 axis.
The study identifies a gut bacteria–liver signaling axis (Lactobacillus johnsonii → hepatic LXRα–SCD1) that may explain how altered hepatic lipids contribute to UC and related liver injury, and shows pristimerin can...
Metabolic reprogramming in ulcerative colitis: integrating dietary drivers, pathogenesis, and therapeutic advances
The review connects Western diet-driven metabolic shifts in the gut, immune cells, and microbiota to ulcerative colitis mechanisms and highlights metabolism-targeting therapies as a potential future avenue for treatment.
Dietary Tryptophan Supplementation Attenuates Lipopolysaccharide-Induced Acute Lung Injury in a Murine Model of Colitis.
The study suggests dietary tryptophan might reduce bacterial-induced acute lung injury in the context of colitis by altering gut–lung immune signaling, which could be relevant to IBD patients who are at risk for...